闻泰科技，最新声明

Core Viewpoint - The company emphasizes the importance of restoring its complete rights as a shareholder and its legitimate control over Nexperia, following the Dutch Ministry of Economic Affairs' decision to suspend the administrative order against Nexperia, which is seen as a first step towards resolving the issue [2][3]. Group 1: Company's Position on the Dutch Ministry's Decision - The company acknowledges the Dutch Minister's statement as a recognition of the current issues and appreciates the efforts of the Chinese Ministry of Commerce in addressing the Nexperia situation [2]. - The suspension of the administrative order indicates the illegality and impropriety of previous actions taken by the Dutch Ministry [2]. - Despite the suspension, the emergency measures imposed by the Dutch court remain in effect, continuing to infringe upon the rights of Chinese shareholders and personnel [2]. Group 2: Obligations of the Dutch Ministry - The administrative order issued on September 30, 2025, is viewed as the beginning of a series of actions by the Dutch government, with the Ministry actively participating in the court proceedings initiated by Nexperia's European management [3]. - The Ministry's involvement included submitting supportive documents to the court and advocating for rapid intervention to prevent potential non-compliance with the administrative order [3]. - The court's emergency measures, which included suspending the positions of Chinese directors and placing a majority of shares under custody, were executed without allowing reasonable representation from Chinese shareholders, indicating a systematic illegal deprivation of the company's rights [3]. Group 3: Restoration of Rights and Control - The company insists that the suspension of the administrative order is not a comprehensive solution and urges the Dutch Ministry to permanently withdraw the order and its involvement in the court proceedings [4]. - A true resolution must be based on restoring the company's complete rights as a shareholder and its legitimate control over Nexperia, reverting the situation to its state prior to September 29, 2025 [4]. - The company will not accept any attempts to legitimize illegal outcomes or a new governance structure created through unlawful processes, and it is prepared to take all legal measures to protect its and all shareholders' rights [4].